Congresso da EAACI 2024: Inovação e Avanços no Tratamento da Alergia
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Durante o congresso serão apresentadas mais de 150 sessões científicas, centradas nos avanços da ciência ambiental, alergias alimentares, inovações em imunoterapia e alergias pediátricas, entre...
EAACI Congress 2024: Innovationen und Fortschritte in der Allergietherapie
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
Im Rahmen des Kongresses werden über 150 wissenschaftliche Vorträge gehalten, die sich unter anderem mit Fortschritten in den Bereichen Umweltwissenschaft, Lebensmittelallergien, Innovationen in der...
EAACI Congress 2024：創新與過敏治療進展
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
大會期間將呈獻超過 150 場科學會議，重點關注環境科學、食物過敏、免疫療法創新和兒童過敏等方面的進展。精準醫療、AI、免疫療法和免疫調節劑將匯聚在此次最大型的過敏和免疫學大會上。大會將於 5 月 31 日至 6 月 3 日在西班牙華倫西亞舉行。 華倫西亞，西班牙, April 30, 2024 (GLOBE NEWSWIRE) -- 歐洲過敏和臨床免疫學會 (European...
EAACI Congress 2024: Innovation and Advances in Allergy Treatment
April 30, 2024 02:58 ET
|
European Academy of Allergy and Clinical Immunology
The EAACI 2024 Congress, by the European Academy of Allergy and Clinical Immunology (EAACI) in Valencia, Spain, from May 31st to June 3rd.
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
April 25, 2024 07:00 ET
|
Purple Biotech Ltd.
Interim data suggests reduced risk of progression or death in the CM24/nivolumab plus standard of care Nal-IRI/5FU/LV arm of the study REHOVOT, Israel, April 25, 2024 (GLOBE NEWSWIRE) --...
International Surrealism Now Exhibition Set to Open in Portugal
February 06, 2024 10:00 ET
|
International Surrealism
Mafra, Portugal, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The much-anticipated "International Surrealism Now" exhibition is set to open its doors from February 5th to 17th, 2024, at the historic Palácio de...
Holaluz cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023
January 31, 2024 03:52 ET
|
Holaluz Clidom SA
Barcelona, 31 de enero de 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023 Holaluz duplica su cuota de mercado...
Holaluz delivers on Normalised EBITDA guidance, reaching 3M€ for FY2023
January 31, 2024 03:52 ET
|
Holaluz Clidom SA
Barcelona, January 31, 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) delivers on Normalised EBITDA guidance, reaching 3M€ for FY2023 Holaluz doubled its solar market share in 2023...
Germany tops the list for Dutch Travellers most visited country
November 22, 2023 01:24 ET
|
Arriving In High Heels Corporation
The Travel App, Visited releases top 10 countries most visited by Dutch travellers. The list includes: Germany, Belgium, France to name a few.
Statkraft kjøper fornybarselskapet Enerfin fra spanske Elecnor Group
November 17, 2023 16:00 ET
|
Statkraft AS
(Oslo/Madrid) Statkraft, Europas største produsent av fornybar energi, har inngått en avtale om å kjøpe det spanske selskapet Elecnor Groups fornybarselskap Enerfin til en pris som tilsvarer en...